What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to provide investors with the final computation of the ratio of earnings to fixed charges, which is a key financial metric related to the company's public offering of senior debt securities.

What does the 'ratio of earnings to fixed charges' indicate?

The ratio of earnings to fixed charges is a measure of a company's ability to cover its fixed financing costs, such as interest and preferred dividends, with its earnings. A higher ratio generally indicates a stronger ability to service its debt obligations.

Why is this information being filed in an 8-K report?

This information is being filed as part of an 8-K to provide a required financial disclosure related to a significant corporate event – the issuance of senior debt securities. It ensures timely dissemination of material information to the public and is incorporated by reference into the company's existing registration statement.

What is the relationship between this 8-K and the Form S-3?

This 8-K filing supplements and incorporates information into Anthem's previously filed Form S-3 Registration Statement (No. 333-101969), which was declared effective in December 2002. The 8-K provides specific financial data relevant to the debt offering that was registered under the S-3.

ELV 8-K SEC Disclosure — Aug 26, 2004

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed this Form 8-K on August 25, 2004, to report on the public offering of its senior debt securities. This filing is in connection with a Registration Statement on Form S-3, which was declared effective in December 2002. The primary purpose of this 8-K is to provide the final computation of the ratio of earnings to fixed charges related to the issuance of these debt securities.

Key Highlights

1Anthem, Inc. is the reporting entity, which is now known as Elevance Health, Inc.
2The filing concerns a public offering of senior debt securities.
3The debt securities were registered under a Form S-3 Registration Statement declared effective on December 24, 2002.
4This 8-K includes Exhibit 12, which contains the final computation of the ratio of earnings to fixed charges for the debt issuance.
5The filing is considered an 'Other Event' under Section 8 of Form 8-K.
6The report was filed on August 25, 2004, with the earliest event date being August 24, 2004.
7Michael L. Smith, Executive Vice President and Chief Financial and Accounting Officer, signed the report.

Elevance Health, Inc. 8-K Report, Corporate Update (Aug 26, 2004)

Summary

Key Highlights

Frequently Asked Questions